Safety update: statins and myasthenia gravis

Drug Ther Bull. 2023 Dec 27;62(1):4. doi: 10.1136/dtb.2023.000063.

Abstract

Overview of: Medicines and Healthcare products Regulatory Agency. Statins: very infrequent reports of myasthenia gravis.Drug Safety Update 2023;17(2):1.

Keywords: Drug-Related Side Effects and Adverse Reactions; Health Care Quality, Access, and Evaluation.

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
  • Myasthenia Gravis* / chemically induced
  • Myasthenia Gravis* / drug therapy

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors